Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehran Karimi

Showing results (171-180 of 315) with videos related to

Pageof 32
Sort By:
BMC Pediatrics|March 2, 2025
Unveiling developmental delays in early childhood: insights from a comparative study of the Bayley Scales (BSID-III) and the ASQ-3 in IranMehran Karimi, Alireza Emarati, Zahra Nafei, et al.
Annals of Hematology|October 24, 2013
Intracranial hemorrhage pattern in the patients with factor XIII deficiencyMajid Naderi, Tahereh Zarei, Sezaneh Haghpanah, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 9, 2013
Comparison of thrombin generation assay with conventional coagulation tests in evaluation of bleeding risk in patients with rare bleeding disordersOmid R Zekavat, Sezaneh Haghpanah, Javad Dehghani, et al.
Indian Pediatrics|February 6, 2007
Bone mineral density in beta-thalassemia major and intermediaMehran Karimi, Alireza Fotouhi Ghiam, Alireza Hashemi, et al.
Hemoglobin|March 23, 2011
Detection of Hb Setif in north Iran and the question of its origin: Iranian or multiethnic?Mohammad Reza Mahdavi, Mehran Karimi, Majid Yavarian, et al.
Pediatric Hematology and Oncology|April 7, 2010
Adverse effects of hydroxyurea in beta-thalassemia intermedia patients: 10 years' experienceMehran Karimi, Nader Cohan, Kazem Mousavizadeh, et al.
Hematology (Amsterdam, Netherlands)|November 22, 2012
Iranian experience of deferasirox (Exjade(®)) in transfusion-dependent patients with iron overload: what is the most effective dose based on serum ferritin levels?Mehran Karimi, Azita Azarkeivan, Soheila Zareifar, et al.
Annals of Hematology|January 12, 2021
The effect of curcumin on serum copper, zinc, and zinc/copper ratio in patients with β-thalassemia intermedia: a randomized double-blind clinical trialMohammadreza Saeidnia, Peyman Nowrouzi-Sohrabi, Mehran Erfani, et al.
Hemoglobin|May 24, 2016
Evaluation of the Relationship Between Hb F Levels and Nucleated Red Blood Cells with Morbidity in Non Transfusion-Dependent Thalassemia PatientsMehran Karimi, Parisa Jooya, Sezaneh Haghpanah, et al.
Journal of Clinical Laboratory Analysis|July 14, 2021
Vitamin D level, lipid profile, and vitamin D receptor and transporter gene variants in sickle cell disease patients from Kurdistan of IraqAbdalla Hussein Hama, Ebrahim Shakiba, Zohreh Rahimi, et al.
Pageof 32

Showing results (171-180 of 315) with videos related to

Sort By:
Pageof 32
BMC Pediatrics|March 2, 2025
Unveiling developmental delays in early childhood: insights from a comparative study of the Bayley Scales (BSID-III) and the ASQ-3 in IranMehran Karimi, Alireza Emarati, Zahra Nafei, et al.
Annals of Hematology|October 24, 2013
Intracranial hemorrhage pattern in the patients with factor XIII deficiencyMajid Naderi, Tahereh Zarei, Sezaneh Haghpanah, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 9, 2013
Comparison of thrombin generation assay with conventional coagulation tests in evaluation of bleeding risk in patients with rare bleeding disordersOmid R Zekavat, Sezaneh Haghpanah, Javad Dehghani, et al.
Indian Pediatrics|February 6, 2007
Bone mineral density in beta-thalassemia major and intermediaMehran Karimi, Alireza Fotouhi Ghiam, Alireza Hashemi, et al.
Hemoglobin|March 23, 2011
Detection of Hb Setif in north Iran and the question of its origin: Iranian or multiethnic?Mohammad Reza Mahdavi, Mehran Karimi, Majid Yavarian, et al.
Pediatric Hematology and Oncology|April 7, 2010
Adverse effects of hydroxyurea in beta-thalassemia intermedia patients: 10 years' experienceMehran Karimi, Nader Cohan, Kazem Mousavizadeh, et al.
Hematology (Amsterdam, Netherlands)|November 22, 2012
Iranian experience of deferasirox (Exjade(®)) in transfusion-dependent patients with iron overload: what is the most effective dose based on serum ferritin levels?Mehran Karimi, Azita Azarkeivan, Soheila Zareifar, et al.
Annals of Hematology|January 12, 2021
The effect of curcumin on serum copper, zinc, and zinc/copper ratio in patients with β-thalassemia intermedia: a randomized double-blind clinical trialMohammadreza Saeidnia, Peyman Nowrouzi-Sohrabi, Mehran Erfani, et al.
Hemoglobin|May 24, 2016
Evaluation of the Relationship Between Hb F Levels and Nucleated Red Blood Cells with Morbidity in Non Transfusion-Dependent Thalassemia PatientsMehran Karimi, Parisa Jooya, Sezaneh Haghpanah, et al.
Journal of Clinical Laboratory Analysis|July 14, 2021
Vitamin D level, lipid profile, and vitamin D receptor and transporter gene variants in sickle cell disease patients from Kurdistan of IraqAbdalla Hussein Hama, Ebrahim Shakiba, Zohreh Rahimi, et al.
Pageof 32